ZLB Behring Foundation Calls For Grant Applications
11/16/2006 11:58:35 AM
More...
|
ZLB Behring Names Robert D. Lefebvre, Ronan W. Gannon, Garrett E. Bergman, M.D., To Top U.S. Management Posts
9/18/2006 10:34:59 AM
More...
|
ZLB Behring Release: VIRTUE, Largest Clinical Trial Of Subcutaneous Immunoglobulin Therapy, Opens To Primary Immunodeficiency Patients Across The U.S.
9/12/2006 12:07:23 PM
More...
|
ZLB Behring Foundation Calls For Grant Applications
6/22/2006 2:01:13 PM
More...
|
ZLB Behring Foundation Awards Grants To Benefit Bleeding Disorders Community
6/5/2006 2:42:05 PM
More...
|
ZLB Behring Release: New International Study Group Seeks To Set Standards For Prevention, Treatment Of Bleeding In Patients With von Willebrand Disease (VWD)
5/23/2006 11:17:36 AM
More...
|
ZLB Behring Release: First International Census On Von Willebrand Disease (VWD): 77 Percent Of Patients With Severe Type 3 VWD Experience Significant Bleeding-Related Events
5/22/2006 11:26:24 AM
More...
|
State-Of-The-Art ZLB Behring Plant Licensed By The FDA
4/18/2006 2:33:41 PM
More...
|
ZLB Behring Release: Study Finds Treatment With C1-Inhibitor Concentrate Relieves Abdominal Pain In Hereditary Angioedema Patients
3/6/2006 11:33:48 AM
More...
|
ZLB Behring Release: Study Shows Individual Replacement Therapy With C1-Inhibitor Concentrate Reduces Life-Threatening Hereditary Angioedema Attacks Compared With Current Treatment Of Choice
3/6/2006 11:13:50 AM
More...
|
|